ScreenIT
The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.
Latest preprint reviews
-
Pulmonary radiological change of COVID-19 patients with 99m Tc-MDP treatment
This article has 17 authors:Reviewed by ScreenIT
-
Carceral Amplification of COVID-19: Impacts for Community, Corrections Officer, and Incarcerated Population Risks
This article has 6 authors: -
COVID-19 pandemic in the African continent: Forecasts of cumulative cases, new infections, and mortality
This article has 9 authors:Reviewed by ScreenIT
-
Colorimetric loop-mediated isothermal amplification (LAMP) for cost-effective and quantitative detection of SARS-CoV-2: the change in color in LAMP-based assays quantitatively correlates with viral copy number
This article has 7 authors:Reviewed by ScreenIT
-
Implementation of a Novel Remote Physician Stereotactic Body Radiation Therapy Coverage Process during the Coronavirus Pandemic
This article has 8 authors:Reviewed by ScreenIT
-
COVID-19 Pandemic and Lockdown Measures Impact on Mental Health Among the General Population in Italy
This article has 10 authors:Reviewed by ScreenIT
-
Airborne particulate matter, population mobility and COVID-19: a multi-city study in China
This article has 16 authors:Reviewed by ScreenIT
-
Associations of clinical characteristics and antiviral drugs with viral RNA clearance in patients with COVID-19 in Guangzhou, China: a retrospective cohort study
This article has 12 authors:Reviewed by ScreenIT
-
Identification of potential vaccine candidates against SARS-CoV-2 , A step forward to fight COVID-19: A Reverse Vaccinology Approach
This article has 3 authors:Reviewed by ScreenIT
-
Discovery of baicalin and baicalein as novel, natural product inhibitors of SARS-CoV-2 3CL protease in vitro
This article has 20 authors:Reviewed by ScreenIT